Patient Compliance with Biotechnological Applications in Gastroenterology

Abstract

Gastroenterology has made a real revolution in medicine by moving in just a few decades, from a medical discipline to a predominantly interventional one. In this context, the issue of the "new" appears, represented by the technological progress in medicine. Acceptance and assimilation of the notion of "new" is configured in the form of a two-way approach, both by the medical community and the patient. In practical approaches, the concept of "new in medicine" explores three levels: communication, the benefit and the risk for the patient. The gastroenterological community responded promptly to the "new" by professionally assimilating biotechnologies designed to improve the patient's quality of life, regardless of age and severity of the disease. This approach requires performance from professionals in the field of interventional gastroenterology, proven by the priority for accuracy in establishing the diagnosis. The performance aims at managerial procedures for the coherent implementation of the technological progress in the digestive endoscopy, in a logical structuring of the activities destined to increase the quality of the medical act, in connection with the duty to do good for the patient. The efficient development of the medical act requires compliance from the patient regarding the adherence to the new medical biotechnologies in the field of endoscopic explorations. An important contribution has the sources of patient information that are both medical and non-medical. Patient compliance with new biotechnologies is directly proportional to the level of trust obtained through effective communication, sensitive to his values ​​and moral beliefs.